Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells

Laura Bianchi, Francesca Bruzzese, Alessandra Leone, Assunta Gagliardi, Michele Puglia, Elena Di Gennaro, Monia Rocco, Anna Gimigliano, Biagio Pucci, Alessandro Armini, Luca Bini, Alfredo Budillon

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds